Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates that reversing KDM6A phosphorylation restores pyroptosis and enhances anti-PD-1 therapy in HNSCC models, suggesting an epigenetic strategy to overcome resistance.
Immune checkpoint blockade (ICB) has revolutionized head and neck squamous cell carcinoma (HNSCC) treatment. Yet, a major barrier to response is that tumor cells are epigenetically reprogrammed to resist immunogenic cell death, particularly pyroptosis. To elucidate how tumor cells are pre-conFigured for pyroptosis resistance, we investigated the role of post-translational modifications on epigenetic regulators, focusing on the phosphorylation-dependent control of histone demethylase KDM6A. Through integrated phosphoproteomics and functional genomics in HNSCC models, we identified phosphorylation of KDM6A at Ser829 as a master regulatory switch. Mechanistically, phosphorylation at Ser829 subverts KDM6A function, leading to a global accumulation of repressive H3K27me3 marks. This establishes an epigenetic program that locks key pyroptosis effector genes ( GSDMD , NLRP3 ) in a transcriptionally refractory, heterochromatic state. To pharmacologically dismantle this barrier, we developed a novel lipid nanoparticle (LNP) system encapsulating mRNA encoding a phosphorylation-defective KDM6A S829A variant. This strategy functionally reverses the oncogenic epigenetic state, restoring endogenous demethylase activity specifically at pyroptosis loci and reigniting the cell death pathway. In vivo, a single administration of KDM6A S829A mRNA inhibited tumor growth by 39% ( p < 0.01). Strikingly, when combined with anti-PD-1, this strategy achieved a synergistic 79% tumor reduction ( p < 0.0001), characterized by robust CD8 + T cell infiltration. Our work identifies KDM6A phosphorylation as a druggable epigenetic-immune checkpoint and establishes mRNA-based modulation of enzyme post-translational status as a transformative paradigm to potentiate ICB in HNSCC.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: